Stay updated on Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.

Latest updates to the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedA banner was added announcing NIH website updates and explaining that some agency content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.5%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, while the study record history remains unchanged.SummaryDifference0.1%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check40 days agoChange DetectedA new revision entry v3.7.0 was added to the history, and the v3.6.6 entry was removed. This reflects an update to the page's revision history tracking.SummaryDifference0.1%

- Check61 days agoChange DetectedThe study's record history now shows a newer revision label (v3.6.6), indicating a newer version of the record. This newer revision supersedes the previous v3.6.5.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history now shows the latest page revision as v3.6.5, replacing the previous v3.6.4 entry in the history, indicating a new build of the ClinicalTrials.gov record.SummaryDifference0.1%

Stay in the know with updates to Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Escalation of RMC-4630 in Solid Tumors Clinical Trial page.